Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Stomach Neoplasms/mortality"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].
To understand the trend of gastric cancer mortality based on the exploration of the death data from 1970 to 2004 in Zhaoyuan County.The death data of 1970-1974 were collected from the first malignant tumor death survey of China, and the data of 1985-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1737af55f8c7ba8e69ef0de364d3d0cf
https://pubmed.ncbi.nlm.nih.gov/17767863
https://pubmed.ncbi.nlm.nih.gov/17767863
Autor:
G, Lundh
Publikováno v:
Nordisk medicin. 86(29)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::988cd881bb68d8b387fd3d8e6a7311f1
https://pubmed.ncbi.nlm.nih.gov/5558492
https://pubmed.ncbi.nlm.nih.gov/5558492
Autor:
Celso A. Reis, Fátima Gärtner, Joana A. Macedo, Filipe Pinto, Joana Gomes, Diana Campos, Rita Matos, Stefan Mereiter, Marta Pinto, António Polónia, Daniela Freitas, Ana Magalhães
Publikováno v:
EBioMedicine
Background: Changes in glycosylation are known to play critical roles during gastric carcinogenesis. Expression of truncated O-glycans, such as the Sialyl-Tn (STn) antigen, is a common feature shared by many cancers and is associated with cancer aggr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06d20d0d2b43cb139e5f78f70b5e130f
http://europepmc.org/articles/PMC6413340
http://europepmc.org/articles/PMC6413340
Autor:
Wagner, A.D., Lordick, F., Grabsch, H.I., Terashima, M., Terada, M., Yoshikawa, T., Boku, N., Kataoka, K., Smyth, E.C., Mauer, M., Haustermans, K., Moehler, M.H.
Publikováno v:
European journal of cancer, vol. 124, pp. 67-76
The aim of this manuscript is to discuss the viewpoint of the European Organisation for Research and Treatment of Cancer (EORTC) Gastric Cancer Taskforce and Japan Clinical Oncology Group (JCOG) Gastric Cancer Study Group on the current challenges in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::7d3d58479982fa0f6100189e4db7d6b2
https://serval.unil.ch/resource/serval:BIB_35163E169A37.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_35163E169A37.P001/REF.pdf
Autor:
Astrid E. Slagter, Maarten C.C.M. Hulshof, Grard A. P. Nieuwenhuijzen, Edwin P.M. Jansen, Geke A. P. Hospers, Richard van Hillegersberg, Karolina Sikorska, Maartje Los, Donald L. van der Peet, Mark I. van Berge Henegouwen, Hanneke W. M. van Laarhoven, Henk Boot, Nicole C.T. van Grieken, Boudewijn van Etten, Annemieke Cats, Johanna W. van Sandick, Henk H. Hartgrink, Heike I. Grabsch, Marcel Verheij, Laurens V. Beerepoot, Pietje Muller-Timmermans, Frank P. J. Peters
Publikováno v:
BMC Cancer, 18(1):877. BioMed Central Ltd
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Cancer, 18:877. BMC
BMC Cancer, 18
BMC cancer, 18(1). BioMed Central
BMC Cancer, 18(1). BioMed Central
BMC Cancer
BMC Cancer, 18. BMC
Slagter, A E, Jansen, E P M, van Laarhoven, H W M, van Sandick, J W, van Grieken, N C T, Sikorska, K, Cats, A, Muller-Timmermans, P, Hulshof, M C C M, Boot, H, Los, M, Beerepoot, L V, Peters, F P J, Hospers, G A P, van Etten, B, Hartgrink, H H, van Berge Henegouwen, M I, Nieuwenhuijzen, G A P, van Hillegersberg, R, van der Peet, D L, Grabsch, H I & Verheij, M 2018, ' CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer ', BMC Cancer, vol. 18, no. 1, pp. 877 . https://doi.org/10.1186/s12885-018-4770-2
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Cancer, 18:877. BMC
BMC Cancer, 18
BMC cancer, 18(1). BioMed Central
BMC Cancer, 18(1). BioMed Central
BMC Cancer
BMC Cancer, 18. BMC
Slagter, A E, Jansen, E P M, van Laarhoven, H W M, van Sandick, J W, van Grieken, N C T, Sikorska, K, Cats, A, Muller-Timmermans, P, Hulshof, M C C M, Boot, H, Los, M, Beerepoot, L V, Peters, F P J, Hospers, G A P, van Etten, B, Hartgrink, H H, van Berge Henegouwen, M I, Nieuwenhuijzen, G A P, van Hillegersberg, R, van der Peet, D L, Grabsch, H I & Verheij, M 2018, ' CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer ', BMC Cancer, vol. 18, no. 1, pp. 877 . https://doi.org/10.1186/s12885-018-4770-2
Contains fulltext : 196889.pdf (Publisher’s version ) (Open Access) BACKGROUND: Although radical surgery remains the cornerstone of cure in resectable gastric cancer, survival remains poor. Current evidence-based (neo)adjuvant strategies have shown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e7b8e7e788dd757dd2f7cc71f3dbf2
https://eprints.whiterose.ac.uk/136426/1/12885_2018_Article_4770.pdf
https://eprints.whiterose.ac.uk/136426/1/12885_2018_Article_4770.pdf
Autor:
Sylvie Lorenzen, Mitsuru Sasako, Wolfgang Blau, Stefan Paul Moenig, A. Wunsch, Karel Caca, Christoph Reissfelder, Frank Mannes, Patrick Michl, Claus Bolling, Thomas Jungbluth, Winfried Padberg, Christian Wilfried Scholz, Ralf Hofheinz, Salah-Eddin Al-Batran, Christoph Benckert, Harald Schmalenberg, Daniel Wilhelm Mueller, Thorsten Oliver Goetze, Alexander Novotny, Nils Homann, C. Roedel, Manish A. Shah, Hakan Alakus, Michael Winkler, Veit Kanngießer, Jorge Riera Knorrenschild, Karl-Hermann Fuchs, Steffen Retter, Claudia Pauligk, Arndt Vogel, Matthias Schwarzbach, Dietmar Lorenz, Michael Hohaus, Wolf O. Bechstein, Thomas Zander, Eva Horndasch, Michael Pohl, Jakob R. Izbicki, Hauke Lang, Julia Gumpp
Publikováno v:
BMC cancer, Vol. 17, No 1 (2017) P. 893
BMC Cancer
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
BMC Cancer
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
Background Historical data indicate that surgical resection may benefit select patients with metastatic gastric and gastroesophageal junction cancer. However, randomized clinical trials are lacking. The current RENAISSANCE trial addresses the potenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83bd435c172de6fbd13a6a344e990ed8
https://doi.org/10.1186/s12885-017-3918-9
https://doi.org/10.1186/s12885-017-3918-9
Autor:
Markus Moehler, Wei Peng Yong, Jingshan Ho, Susanne Unverzagt, Wilfried Grothe, Anna Dorothea Wagner, Nicholas Syn, Bee Choo Tai
Publikováno v:
The Cochrane Library
The Cochrane database of systematic reviews, vol. 8, pp. CD004064
The Cochrane database of systematic reviews, vol. 8, pp. CD004064
Background Gastric cancer is the fifth most common cancer worldwide. In "Western" countries, most people are either diagnosed at an advanced stage, or develop a relapse after surgery with curative intent. In people with advanced disease, significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4d449a6958393810f646e84962d016c
https://doi.org/10.1002/14651858.cd004064.pub4
https://doi.org/10.1002/14651858.cd004064.pub4
Publikováno v:
Annals of Oncology, vol. 19, no. 4, pp. 631-640
Background Cancer mortality peaked in the European Union (EU) in the late 1980s and declined thereafter. Materials and methods We analyzed EU cancer mortality data provided by the World Health Organization in 1970–2003, using joinpoint analysis. Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78a4183cfdb9f31b51c598f8ffbdef93
http://doc.rero.ch/record/300897/files/mdm597.pdf
http://doc.rero.ch/record/300897/files/mdm597.pdf